Health ❯Healthcare ❯Pharmaceuticals ❯Drug Approval

FDA Regulations

Mounjaro Rivals Trulicity in Cardiovascular Safety and Lowers All-Cause Mortality

The results pave the way for a regulatory submission this year targeting a 2026 cardiovascular label expansion.

FDA Launches National Priority Voucher Program to Slash Drug Review Times

FDA Approves Neffy, the First Needle-Free Epinephrine Nasal Spray for Anaphylaxis